A Antilli

Platinum-Etoposide Chemotherapy in Elderly Patients With Small-Cell Lung Cancer: Results of a Randomized Multicenter Phase II Study Assessing Attenuated-Dose or Full-Dose With Lenograstim Prophylaxis—A Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) Study

Andrea Ardizzoni, Adolfo Favaretto, Luca Boni et al. · Journal of Clinical Oncology · 2005 · 88 citations · Full text

Medicine, Oncology, Pharmacology +16

Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.

F Salvati, Guido Rasi, L Portalone et al. · PubMed · 1996 · 45 citations

Medicine, Hematology, Oncology +15

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study

Editta Baldini, Carmelo Tibaldi, Andrea Ardizzoni et al. · British Journal of Cancer · 1998 · 27 citations · Full text

Medicine, Oncology, Pharmacology +14

Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?

Enzo Ballatori, Fausto Roila, Maurizio Tonato et al. · Annals of Oncology · 1997 · 24 citations

Medicine, Oncology, Pharmacotherapy +11

Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer: Multicentric randomized FONICAP trial report

Andrea Ardizzoni, Franco Salvati, Riccardo Rosso et al. · Cancer · 1993 · 23 citations

Medicine, Oncology, Pharmacology +14